Phase II clinical study on combination of oxaliplatin (L-OHP) and S-1 in advanced / recurrent gastric cancer untreated with chemotherapy
Phase 2
- Conditions
- Gastric cancer
- Registration Number
- JPRN-jRCT2080220365
- Lead Sponsor
- Yakult Honsha Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Gastric cancer confirmed by histological diagnosis or cytologic diagnosis
- Unresectable advanced / recurrent gastric cancer
- Age of 20 years or older
- Not pretreated with chemotherapy drugs, immunotherapeutic drugs, or radiation therapy
- ECOG Performance Status 0 to 2
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response Rate
- Secondary Outcome Measures
Name Time Method